Geographic atrophy: Clinical impact and emerging treatments

Ophthalmic Surgery Lasers and Imaging Retina

Volumn 46, Issue 1, 2015, Pages 8-13

  Patel, Hershel R ^a   Eichenbaum, David ^b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b Retina Associates of Florida   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS ACTING ON THE EYE; AMYLOID; ANTIINFLAMMATORY AGENT; ANTILIPEMIC AGENT; FENRETINIDE; NEUROPROTECTIVE AGENT;

AGE RELATED MACULAR DEGENERATION; ARTICLE; BODY MASS; CELL LOSS; CHOROID; CHOROID CAPILLARY LAYER; DISEASE COURSE; DRUSEN; GEOGRAPHIC ATROPHY; HUMAN; HYPERPIGMENTATION; HYPERTENSION; MULTICENTER STUDY (TOPIC); NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PERFUSION; PHASE 2 CLINICAL TRIAL (TOPIC); PHOTORECEPTOR; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SMOKING; STEM CELL TRANSPLANTATION; ANIMAL; BLINDNESS; CELL SURVIVAL; COMPLICATION; PATHOLOGY; PHOTORECEPTOR CELL;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BLINDNESS; CELL SURVIVAL; GEOGRAPHIC ATROPHY; HUMANS; OXIDATIVE STRESS; PHOTORECEPTOR CELLS, VERTEBRATE; RETINAL PIGMENT EPITHELIUM; STEM CELL TRANSPLANTATION;

EID: 84920722536     PISSN: 23258160     EISSN: 23258179     Source Type: Journal    
DOI: 10.3928/23258160-20150101-01     Document Type: Article

References (23)

1. Lim LS, Mitchell P, Seddon JM, Holz FG, Wong TY. Agerelated macular degeneration. Lancet. 2012?379(9827):1728-1738. doi:10.1016/S01406736(12)602827 [CrossRef]
2. Bhutto I, Lutty G. Understanding agerelated macular degeneration (AMD): relationships between the photoreceptor/retinal pigment epithelium/Bruch's membrane/choriocapillaris complex. Mol Aspects Med. 2012?33(4):295-317. doi:10.1016/j.mam.2012.04.005 [CrossRef]
3. Sunness JS. The natural history of geographic atrophy, the advanced atrophic form of agerelated macular degeneration. Mol Vis. 1999?5:25.
4. Holz FG, Strauss EC, SchmitzValckenberg S, van Lookeren Campagne M. Geographic atrophy: clinical features and potential therapeutic approaches. Ophthalmology. 2014?121(5):1079-1091. doi:10.1016/j.ophtha.2013.11.023 [CrossRef]
5. Tomany SC, Wang JJ, Van Leeuwen R, et al. Risk factors for incident agerelated macular degeneration: pooled findings from 3 continents. Ophthalmology. 2004?111(7):1280-1287. doi:10.1016/j.ophtha.2003.11.010 [CrossRef]
6. Coleman HR, Chan CC, Ferris FL 3rd, Chew EY. Agerelated macular degeneration. Lancet. 2008?372(9652):1835-1845. doi:10.1016/S01406736(08)617596 [CrossRef]
7. Chew EY, Clemons TE, Agr?n E, et al. AgeRelated Eye Disease Study Research Group. Longterm effects of vitamins C and E, ?carotene, and zinc on agerelated macular degeneration: AREDS report no. 35. Ophthalmology. 2013?120(8):1604-1611. doi:10.1016/j.ophtha.2013.01.021 [CrossRef]
8. Damico FM, Gasparin F, Scolari MR, Pedral LS, Takahashi BS. New approaches and potential treatments for dry agerelated macular degeneration. Arq Bras Oftalmol. 2012?75(1):71-6.
9. Tatton W, Chen D, ChalmersRedman R, Wheeler L, Nixon R, Tatton N. Hypothesis for a common basis for neuroprotection in glaucoma and Alzheimer's disease: antiapoptosis by alpha2adrenergic receptor activation. Surv Ophthalmol. 2003?48Suppl 1:S25-37 doi:10.1016/S00396257(03)000055 [CrossRef]
10. ClinicalTrials.gov Identifier: NCT00658619. Safety and Efficacy of Brimonidine Intravitreal Implant in Patients With Geographic Atrophy Due to Agerelated Macular Degeneration (AMD). http://clinicaltrials.gov/ct2/show/NCT00658619?term=NCT00658619&rank=1
11. ClinicalTrials.gov Identifier: NCT02087085. A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Agerelated Macular Degeneration (BEACON). http://clinicaltrials.gov/ct2/show/study/NCT02087085?term=brimonidine+geographic&rank=2
12. Tsao SW, Fong DS. Do statins have a role in the prevention of agerelated macular degeneration? Drugs Aging. 2013?30(4):205-213. doi:10.1007/s4026601300614 [CrossRef]
13. Johnson LV, Leitner WP, Rivest AJ, Staples MK, Radeke MJ, Anderson DH. The Alzheimer's A beta peptide is deposited at sites of complement activation in pathologic deposits associated with aging and agerelated macular degeneration. Proc Natl Acad Sci U S A. 2002?99(18):11830-11835. doi:10.1073/pnas.192203399 [CrossRef]
14. Leyhe T, Andreasen N, Simeoni M, et al. Modulation of betaamyloid by a single dose of GSK933776 in patients with mild Alzheimer's disease: a Phase I study. Alzheimers Res Ther. 2014?6(2):19. doi:10.1186/alzrt249 [CrossRef]
15. SchmitzValckenberg S, Alten F, Steinberg JS, et al. Geographic Atrophy Progression (GAP) Study Group. Reticular drusen associated with geographic atrophy in agerelated macular degeneration. Invest Ophthalmol Vis Sci. 2011?52(9):5009-5015. doi:10.1167/iovs.117235 [CrossRef]
16. Chiou C. Is dry AMD treatable? Retina Today. May2012. http://bmctoday.net/retinatoday/2012/05/article.asp?f=isdryamdtreatable
17. Mathis AE. Hope for dry AMD? Retinal Physician. http://www.retinalphysician.com/articleviewer.aspx?articleID=107893
18. Schmitz-Valckenberg S, Mössner A, Fleckenstein M, Wiedemann P, Holz FG. [Therapy approaches for geographic atrophy]. Ophthalmologe. 2010?107(11):1016-1019. doi:10.1007/s0034701021605 [CrossRef]
19. Mata NL, Lichter JB, Vogel R, Han Y, Bui TV, Singerman LJ. Investigation of oral fenretinide for treatment of geographic atrophy in agerelated macular degeneration. Retina. 2013?33(3):498-507. doi:10.1097/IAE.0b013e318265801d [CrossRef]
20. http://www.amd.org/research/dryamdresearch/dryamdclinicaltrials/52fenretinidepill.html
21. Roche. Investor update. August 27, 2013. http://www.roche.com/investors/ir-update/invupdate20130827.htm
22. Schwartz SD, Hubschman JP, Heilwell G, et al. Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet. 2012?379(9817):713-720. doi:10.1016/S01406736(12)600282 [CrossRef]
23. ClinicalTrials.gov Identifier: NCT01344993. Safety and Tolerability of Subretinal Transplantation of hESC Derived RPE (MA09hRPE) Cells in Patients With Advanced Dry Age Related Macular Degeneration (Dry AMD). http://clinicaltrials.gov/ct2/show/NCT01344993?term=MA09&rank=4